Paper · 2026 · Open access

ADMET

Medina Khairani

Open Science Framework · Published 1 January 2026 · DOI 10.17605/osf.io/24c6j

Read the free full textCite this paper

In brief

“ADMET” is a 2026 paper by Medina Khairani, published in Open Science Framework. OpenAlex counts 0 citations as of 16 November 2026. It is open access: the full text is free to read at Open Science Framework.

Citations
0
Authors
1

Abstract

ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) represents a fundamental aspect of modern drug discovery and development, determining the efficacy, safety, and clinical success of candidate compounds. Early evaluation of ADMET parameters is essential to minimize clinical failures caused by poor bioavailability, metabolic instability, or unexpected toxicity. Bioavailability refers to the fraction of an administered drug that reaches systemic circulation in its active form, while Lipinski’s Rule of Five serves as a guideline for assessing the oral drug-likeness of small molecules. With the advancement of computational technology, various in silico tools such as SwissADME, pkCSM, ADMETlab, admetSAR, PreADMET, and Molinspiration have been widely used to predict and optimize pharmacokinetic and toxicological profiles prior to experimental validation. These approaches integrate QSAR modeling, machine learning, and physicochemical descriptors such as logP, TPSA, and molecular weight to estimate absorption, tissue distribution, enzymatic metabolism, excretion, and toxicity potential. By combining computational and experimental strategies, the drug discovery process becomes more efficient, cost-effective, and increases the likelihood of advancing compounds into clinical development.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Khairani, M. (2026). ADMET. Open Science Framework. https://doi.org/10.17605/osf.io/24c6j

MLA 9

Khairani, Medina. “ADMET.” Open Science Framework, 2026. https://doi.org/10.17605/osf.io/24c6j.

Chicago

Khairani, Medina. 2026. “ADMET.” Open Science Framework. https://doi.org/10.17605/osf.io/24c6j.

Harvard

Khairani, M. (2026) ‘ADMET’, Open Science Framework. doi:10.17605/osf.io/24c6j.

IEEE

M. Khairani, “ADMET,” Open Science Framework, 2026, doi: 10.17605/osf.io/24c6j.

BibTeX

@article{khairani2026admet,
  title     = {{ADMET}},
  author    = {Khairani, Medina},
  journal   = {Open Science Framework},
  year      = {2026},
  doi       = {10.17605/osf.io/24c6j},
  url       = {https://doi.org/10.17605/osf.io/24c6j}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • ADMET properties
  • drug discovery
  • bioavailability
  • pharmacokinetics
  • toxicity prediction
  • Lipinski's rule of five
  • QSAR
  • machine learning

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Khairani, M. (2026). ADMET. Open Science Framework. https://doi.org/10.17605/osf.io/24c6j

How many times has this paper been cited?

0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Open Science Framework.

Who wrote this paper?

Medina Khairani.

What is the DOI of this paper?

10.17605/osf.io/24c6j. The permanent link is https://doi.org/10.17605/osf.io/24c6j.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.